Literature DB >> 10941

Comparison of the residual effects of two benzodiazepines (nitrazepam and flurazepam hydrochloride) and pentobarbitone sodium on human performance.

R G Borland, A N Nicholson.   

Abstract

1 The residual effects of two benzodiazepines, nitrazepam (10 mg) and flurazepam hydrochloride (30 mg), and pentobarbitone sodium (200 mg) were studied by adaptive tracking and by reaction time. Performance was measured at 10 h, 13 h, 16 h, 19 h and 34 h after ingestion of each drug. Impaired performance on adaptive tracking was observed at 10 h, 13 h, 16 h and 19 h after nitrazepam and pentobarbitone sodium and at 10 h, 13 h and 16 h after flurazepam hydrochloride. Enhanced performance was observed at 34 h after nitrazepam and pentobarbitone sodium. 2 Increased reaction time persisted to 16 h after nitrazepam, flurazepam hydrochloride and pentobarbitone sodium and reaction time was also increased at 34 h after nitrazepam and pentobarbitone sodium. 3 During the morning immediately after ingestion, the subjects as a group were able to differentiate correctly between placebo and drugs, but they were not able to assess accurately the persistence of the residual effects of nitrazepam and pentobarbitone sodium. 4 Flurazepam hydrochloride would appear to be a more promising benzodiazepine than nitrazepam for use as a hypnotic by persons involved in skilled activity. There was a rapid recovery of performance during the afternoon and, unlike pentobarbitone sodium and nitrazepam, subjects retained the ability to recognize impaired skill.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 10941      PMCID: PMC1402497          DOI: 10.1111/j.1365-2125.1975.tb00465.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  A comparison of hypnotic and residual psychological effects of single doses of chlorpromazine and secobarbital in man.

Authors:  C KORNETSKY; T S VATES; E K KESSLER
Journal:  J Pharmacol Exp Ther       Date:  1959-09       Impact factor: 4.030

2.  Drives and the C.N.S. (conceptual nervous system).

Authors:  D O HEBB
Journal:  Psychol Rev       Date:  1955-07       Impact factor: 8.934

3.  The persistence of mental impairment following a hypnotic dose of a barbiturate.

Authors:  J M VON FELSINGER; L LASAGNA; H K BEECHER
Journal:  J Pharmacol Exp Ther       Date:  1953-11       Impact factor: 4.030

4.  Absorption and clearance of secobarbital, heptabarbital, methaqualone, and ethinamate.

Authors:  J M Clifford; J H Cookson; P E Wickham
Journal:  Clin Pharmacol Ther       Date:  1974-08       Impact factor: 6.875

5.  Hypnotics and altered sleep-dream patterns. I. All-night EEG studies of glutethimide, methyprylon, and pentobarbital.

Authors:  A Kales; T A Preston; T L Tan; C Allen
Journal:  Arch Gen Psychiatry       Date:  1970-09

6.  Impaired performance on delayed matching in monkeys by heptabarbitone, pentobarbitone sodium and quinalbarbitone sodium.

Authors:  A N Nicholson; C M Wright; H M Ferres
Journal:  Neuropharmacology       Date:  1973-04       Impact factor: 5.250

7.  The residual effects of flurazepam.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1973-09-28

8.  Residual effects of hypnotics.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1972

9.  Metabolism of flurazepam, a benzodiazepine, in man and dog.

Authors:  M A Schwartz; E Postma
Journal:  J Pharm Sci       Date:  1970-12       Impact factor: 3.534

10.  Persistent behavioural and electroencephalographic changes after single doses of nitrazepam and amylobarbitone sodium.

Authors:  A Malpas; A J Rowan; C R Boyce; D F Scott
Journal:  Br Med J       Date:  1970-06-27
View more
  40 in total

1.  Proceedings: Effect of diazepam and a soluble salt of diazepam (fosazepam) on sleep in man.

Authors:  C H Clarke; H M Ferres; A N Nicholson; B M Stone
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  Some problems of high speed travel.

Authors:  D C Reader
Journal:  Postgrad Med J       Date:  1975-12       Impact factor: 2.401

3.  Alterations in brain 5-hydroxytryptamine metabolism during the 'withdrawal' phase after chronic treatment with diazepam and bromazepam.

Authors:  R A Agarwal; Y D Lapierre; R B Rastogi; R L Singhal
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

Review 4.  Clinical pharmacokinetics of hypnotics.

Authors:  D D Breimer
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

5.  Effect of diazepam and fosazepam (a soluble derivative of diazepam) on sleep in man.

Authors:  A N Nicholson; B M Stone; C H Clarke
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

6.  Performance studies with antihistamines.

Authors:  C H Clarke; A N Nicholson
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

7.  Flurazepam hydrochloride and its principal metabolites: behavioural studies in the monkey (Macaca mulatta).

Authors:  C M Bradley; A N Nicholson
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 8.  Residual effects of hypnotics: epidemiology and clinical implications.

Authors:  Annemiek Vermeeren
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Behavioural sequelae of methaqualone in man and in the monkey (Macaca mulatta).

Authors:  R G Borland; A N Nicholson; C M Wright
Journal:  Br J Clin Pharmacol       Date:  1975-04       Impact factor: 4.335

10.  Toxicity of nitrazepam in the elderly: a report from the Boston Collaborative Drug Surveillance Program.

Authors:  D J Greenblatt; M D Allen
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.